|
|
|
Volumn 158, Issue 2134, 1998, Pages 20-21
|
|
The price of profit
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NEW DRUG;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
FINANCIAL MANAGEMENT;
GENETICS;
GENETICS AND REPRODUCTION;
GOVERNMENT;
HEALTH CARE ORGANIZATION;
HUMAN;
HUMAN GENOME PROJECT;
INDUSTRY;
INFORMATION DISSEMINATION;
INFORMATION SERVICE;
NATIONAL INSTITUTES OF HEALTH;
NUCLEOTIDE SEQUENCE;
ORGANIZATION;
ORGANIZATION AND MANAGEMENT;
PATENT;
POLICY;
RISK;
RISK ASSESSMENT;
SOCIAL CHANGE;
UNITED STATES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
GENETICS AND REPRODUCTION;
HUMAN GENOME PROJECT;
NATIONAL INSTITUTES OF HEALTH;
ACADEMIES AND INSTITUTES;
BASE SEQUENCE;
DRUGS, INVESTIGATIONAL;
FEDERAL GOVERNMENT;
FINANCING, GOVERNMENT;
GENETIC RESEARCH;
GENETICS;
GOVERNMENT;
HUMAN GENOME PROJECT;
HUMANS;
INDUSTRY;
INFORMATION DISSEMINATION;
INFORMATION SERVICES;
NATIONAL INSTITUTES OF HEALTH (U.S.);
ORGANIZATIONAL POLICY;
OWNERSHIP;
PATENTS;
RISK;
RISK ASSESSMENT;
SOCIAL CHANGE;
UNITED STATES;
|
|
EID: 0032537223
PISSN: 02624079
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|